Research is additionally ongoing to define endpoints in addition to abstinence for measuring treatment efficacy, for instance clinically significant reductions in drug use connected with advancements in health outcomes (95). These kinds of changes could decrease the regulatory bar for acquiring FDA approval for new therapeutics. As an example, anal